TSS
CBIO

Two Sigma Securities’s Crescent Biopharma CBIO Stock Holding History

Two Sigma Securities’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-157
Closed -$3.31K – 1722
2025
Q1 		$3.31K Buy
+157
New +$4.2K ﹤0.01% 1328
2024
Q4 		– Sell
-222
Closed -$3.75K – 2353
2024
Q3 		$3.75K Buy
+222
New +$4.66K ﹤0.01% 2685
2023
Q3 		– Sell
-110
Closed -$19.1K – 3233
2023
Q2 		$19.1K Buy
+110
New +$18.4K ﹤0.01% 2515

Other funds holding CBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return